JT Garwood
Verenigde Staten
6K volgers
Meer dan 500 connecties
Gemeenschappelijke connecties met JT weergeven
JT kan u introduceren bij 6 mensen bij bttn
of
Nog geen lid van LinkedIn? Word nu lid
Door op Doorgaan te klikken om deel te nemen of u aan te melden, gaat u akkoord met de gebruikersovereenkomst, het privacybeleid en het cookiebeleid van LinkedIn.
Gemeenschappelijke connecties met JT weergeven
of
Nog geen lid van LinkedIn? Word nu lid
Door op Doorgaan te klikken om deel te nemen of u aan te melden, gaat u akkoord met de gebruikersovereenkomst, het privacybeleid en het cookiebeleid van LinkedIn.
Activiteit
6K volgers
-
JT Garwood heeft dit gedeeldFrontera is a bright light in healthcare. I’ve had more AI-in-healthcare debates than I can count, but this one gets the crowd buzzing. I sent a cold email with a snazzy hook about the opportunities in healthcare distribution to Amol Deshpande years ago which led to our first check—and he’s since become a mentor, friend, and someone I deeply admire. There are few builders who truly grasp both the barriers within healthcare and the upside technology can provide antiquated industry like he does. Huge congrats to the Frontera team! 💥JT Garwood heeft dit gedeeldBig News! I am back and with a purpose. Announcing Frontera and our $32M seed investment from Lux Capital, Lightspeed, Bison Ventures, Inspired Capital and Menlo Ventures. Our mission is access to care in autism and early childhood conditions. My son was diagnosed when he was 2/3 years old. 10 years later, it is hard to believe he is the same kid- back then he couldn't talk or respond to his name. Now, I have a thriving 13 year old. Incredible. I am a specialist- I go deep on things. Many of you know me as an agtech entrepreneur- perhaps the most accomplished in the industry. I love ag and will remain an investor. This is something I had to do. Its an opportunity for transformative impact- and much like ag, I have become an expert and specialist through experience and investment. What is Frontera? Frontera is a deeptech innovation in autism and early childhood conditions that uses Digital Phenotyping, which we do by extracting clinical data at 30 frames per second from video. This radical change in data collection can be applied beyond autism. We have taken 18 months to announce because it took that long to get to a V0, which is now available. We have also released AI products focused on assessment and diagnosis. There are 3X as many kids who need intervention relative to those who get it- 5X in rural markets. We cannot ask clinicians simply to work more hours. We need innovation. Today, data is collected through basic systems/software that deters from the therapy. Passive data collection, longitudinal analysis, asynchronous supervision, quality control and faster assessment/diagnosis can mean transformative care. Frontera can reduce waitlists and time to therapy. Clinicians and parents alike will have a plethora of data and precision to leverage their time. We will be releasing demonstrations of this technology and all that we do in the coming weeks. We care about access to care and precision. We will work with ANYONE who is interested in that. We will: - Provide discounts on technology to anyone who : - is a ".org" or non profit - Currently works in a rural or destitute market - Anyone serving medicaid or low income - Work with any player in the market, including competitors- we are an open system and nobody will be denied - Performing critical research in autism - Wants to bring down cost of diagnosis, assessment and therapy This will not be cheap or easy, but only hard things are worth doing. We have an amazing team and investors. Thank you to Bilal Zuberi, Galym Imanbayev, MD, Tom Biegala, Alexa von Tobel, Matt Murphy and my team including Manu Kohli,Ph.D, Jeff Flores, Grant Sickle, Sara Williams, Jeffrey Kamei, Alex Buchholz, Nate Phillips, Om Patel among many others. Thanks to Erin B. as well for covering us! #frontera #autism #entrepreneur https://lnkd.in/g-Cttuu8Early Autism Detection Digital Phenotyping Technology | FronteraEarly Autism Detection Digital Phenotyping Technology | Frontera
-
JT Garwood heeft dit gedeeldWould love my network to show this some love on product hunt! Go bttn. Go!JT Garwood heeft dit gedeeldWE ARE LIVE ON PRODUCT HUNT! GO SHOW YOUR SUPPORT! "Customers subscribe and save, much like an amazon prime experience, but for their B2B medical supply needs." Check us out! https://lnkd.in/gNv8S-k #technology #medical #innovation #manufacturing #healthcare #digitalhealth #healthtech #healthinnovation #automation #medicalsupply #healthcareindustry #tech #startup #upvote #b2b
-
JT Garwood heeft dit gedeeldWith seemingly every news story being about COVID-19 #Testing, its important to understand the language that is used and the differences between available testing. Whether you're getting tested or making a decision for how your organization is supporting the effort to ensure employee safety- this article will help set some baselines. Big Tech, Major Retailers, Pharmaceuticals, Logistics/ Autonomous Deliveries- all entering the same market. Lot's of very interesting overlap. Read more about testing categories and reach out to me directly if you're organization needs help understanding testing and what you can do to support your employee's testing. #PPEx #covid19testingJT Garwood heeft dit gedeeld"As we trek deeper into this ‘new normal’ where attempts at contact-tracing and rapid testing make global headlines, healthcare professionals and businesses alike must understand not only the details of each test type, but how to purchase each type of test." Join PPE Exchange and our network of verified vendors in solving the #Covid19 testing problem. #healthcare #rapidtest #pcrtest #moleculartesting #ppe #blockchain https://lnkd.in/gkRiPEq
-
JT Garwood heeft dit gedeeldAwesome things happening here in the Federal Civilian Space at Microsoft. With our second newsletter comes a focus on security. Take a read on the latest and greatest from Microsoft and learn how we are better helping secure our Federal Agency's data. Shoot me a note if you'd like to be included in future distributions! #MSFT #Security #Federal #CASB #SecureScore https://lnkd.in/edVJTeZ
-
JT Garwood heeft hierop gereageerdJT Garwood heeft hierop gereageerdGrateful for the opportunity to step into the Partner role at NewView Capital and even more grateful to keep doing the work I love alongside founders and this team.
-
JT Garwood vond dit interessantJT Garwood vond dit interessantVeterans Day always makes me pause. For me, service has never just been about the uniform. It’s about the values that stay with you long after you hang it up: discipline, teamwork, and a deep sense of duty to something bigger than yourself. To all who’ve served and to the families who’ve stood beside them, thank you. The sacrifices, the lessons, and the bonds forged in service continue to make our world a better place.
-
JT Garwood heeft hierop gereageerdJT Garwood heeft hierop gereageerdThrilled to share some incredible news! Today, we announced Blueprint's $60 million raise. This is a major milestone in bringing Bryan Johnson's longevity protocol to the world. I’m joining Bryan Johnson and Kate Tolo as CEO to help build the system I’ve always believed should exist, one that helps people feel their best, think clearly, and live longer, healthier lives. Our society is facing an epidemic of poor health, physically, mentally, and emotionally. Blueprint is taking a radically different approach. We’re building a complete health system designed to help people reclaim control of their bodies and minds, guided by data, measurement, and science, not hype. For me, this is deeply personal. I’ve spent my entire career building systems that make healthcare more accessible and effective — from Google Health to Lyft Healthcare to Modern Health. Blueprint is the next evolution of that mission. I’m beyond excited to partner with Bryan Johnson and Kate Tolo, two people who are reimagining what’s possible for human health and longevity. We are on a journey to build a team and product that will help millions of people feel and function at their best. This is just the beginning. Let’s go build the future of health. Early Access: https://lnkd.in/gJRaXzai Blueprint - Bryan Johnson - Kate Tolo
-
JT Garwood heeft hierop gereageerdJT Garwood heeft hierop gereageerdIt was an incredible year at Pinecone. A truly formative time for me that I’ll reflect on with fondness, lasting connections, mentors, and meaningful career enrichment. Excited to watch this team continue to dominate the vector db space! I'm beyond stoked for this next chapter: I’ve joined the User Ops team at Cursor! I couldn’t be more excited to help shape and accelerate Technical Support here - changing the future of software engineering. Let's go!
-
JT Garwood vond dit interessantJT Garwood vond dit interessantalright, let's try this startup thing one more time, eh?
-
JT Garwood vond dit interessantJT Garwood vond dit interessantI am beyond excited to share that I will be joining Appian as Senior Vice President of Public Sector. I am very thankful to the Appian Founders and Leadership Team for their confidence in me and to join new colleagues to build something remarkable together. What drew me to Appian is the opportunity to help Public Sector customers and their constituents achieve actual business value with a holistic and modern AI-powered process Platform. I will be focusing on scaling a world-class go-to-market organization, building upon an already amazing culture, and accelerating our growth. Be on the lookout for us, we will be everywhere. Ya'll ready? Matt Calkins, Mark Dorsey, Michael Beckley, Robert Kramer, Marc Wilson, Michael Mayer, Bill Lyons, Scott Van Valkenburgh, Gregg Aldana, Susan Charnaux, David Crozier, Li Ma, Chris Malloy, Ahson Wardak, Frank DeGeorge, Michael Wright, Dan Kenny, Stephanie Bogdanovic, Gary Stephens, Scott Woestman, Richard Clos, Alyssa Ashworth, Jason Adolf, Yvonne Downie, Kim Dinerman, Hal Walker, Nathan Harper, Ari Mukherjee, Emily Lane, Michael Schwartz, Dina Spivy
-
JT Garwood heeft hierop gereageerdJT Garwood heeft hierop gereageerdI got into YC solo, and it's the loneliest thing I've done. When I applied to YC, I told them I wasn't looking for a cofounder. During my first interview, they asked about it. I told them I wasn't looking. I then had a 45 minute second interview. They told me to go find a cofounder. They said, "we won't make your acceptance contingent on this, but you're gonna want one." I tried to convince my smartest friends to join, but wtf would they? I had no traction, no idea, and certainly no story to tell. Hell, I wouldn't have joined me had I heard the pitch. Sorry, fella. But obviously I wasn't gonna say no to yc. So, I went through it solo. Barely raised. Pivoted for 9 months after the batch with ZERO traction. I had no direction to build toward, which meant I had no purpose as a person. It was likely the worst year of my life. If I'm being honest, I probably didn't give up b/c I would have been ashamed to be someone who gave up. I'm not sure what the lesson is here, but if you see a solo founder, give em a hug.
-
JT Garwood heeft hierop gereageerdThe kids call this cooking. Proud investor in Amjad Masad and the entire Replit team as they give 8B people the power of the worlds best codersJT Garwood heeft hierop gereageerdExcited to announce Replit’s $250M Series C at a $3B valuation! Led by Prysm, with new investors like Amex and Google joining. Our earliest believers—YC, Craft, a16z, Coatue, Paul Graham, and others—are doubling down. For 10 years we’ve been chasing a dream: empowering a billion people to create software without needing to code. That dream is now becoming reality—whether it’s solo founders launching startups or enterprises like Zillow and Duolingo transforming how they build software. This funding lets us accelerate: - Push the frontier of autonomous coding agents - Scale operations - Expand globally We’re only ~100 people today. It’s still early. If you want to have an outsized impact on the future of software—now’s the time to join.
Ervaring
Opleiding
Bekijk het volledige profiel van JT
-
Bekijk wie u allebei kent
-
Word voorgesteld
-
Neem rechtstreeks contact op met JT
Overige vergelijkbare profielen
Meer bijdragen onderzoeken
-
Jai Vardhan
Entrackr • 21K volgers
SCOOP: Swish is raising $30 Mn in a fresh round at a valuation jump of over 2.4X within a year of its last fundraiser. What stands out isn’t just the capital, it’s the timing. The 10-minute food delivery model is proving harder than expected. Several large players have already pulled back, citing operational complexity and uneven demand. Yet, Swish is doubling down on the same playbook with a hyperlocal, cloud kitchen-led approach. This is what makes the bet interesting. In consumer internet, outcomes are rarely linear. Categories often look unviable until someone cracks execution. Swish is entering a space where others have stepped back. That could either mean the model is broken, or that it’s still early.
44
2 commentaren -
Siddhartha Ahluwalia
Neon • 49K volgers
Recko’s $150M Exit to Stripe. I sat down with Co-Founder Saurya Prakash Sinha to unpack the story behind one of India’s biggest B2B SaaS acquisitions — and what it really takes to build for a $100M+ outcome. We dive deep into: 1. Why companies get acquired? 2. How companies are evaluated for Acquisitions? 3. Why $100M+ Acquisitions are rare? 4. How to Build if there's Zero Validation? 5. Why Stripe understood what VC's couldn't 6. How to raise when investors follow success playbooks? 7. How to find the real value your product adds? 8. What to expect when building products in finance? 9. What did Recko solve for Myntra that Big Four couldn’t? Watch the full episode: Youtube: https://lnkd.in/gwW84mur Spotify: https://lnkd.in/gGHMCqV8 Apple: https://lnkd.in/gDSesRm3
62
2 commentaren -
Hadley Harris
ENIAC Ventures • 21K volgers
If you look at the early-stage fundraising funnel, conversion rates are tightening, but the companies that do raise are doing so at higher valuations and with larger checks. The market seems to be betting on fewer winners, but those winners will be bigger. I’m not convinced. I do believe the very biggest winners will be larger than ever as AI expands the reach of technology, largely by replacing labor. But I don’t believe there will be fewer winners overall. Most B2B solutions are moving toward verticalized, specialized use cases that deliver superior value compared to generalized horizontal platforms. That shift should create more winners. While these vertical players may not reach the scale of the horizontal mega-winners, they can still generate the kind of multibillion-dollar outcomes that venture is built to fund.
57
9 commentaren -
Martyn Eeles
Clarma Capital • 12K volgers
Founders obsess over valuation. Investors obsess over terms. Only one of these determines what you actually walk away with. Today’s new HealthVC breaks down the round math that silently shapes founder outcomes. How preferences reshape downside. How participation erodes liquidity. How anti-dilution moves future pain. How option pools rewrite ownership. How pro rata defines who stays powerful as you scale. If you want to protect your future self before signing a term sheet, this is the edition to read.
8
-
Ethan Hochberg
MarketingGuys • 2K volgers
If you're relying on one revenue stream, it's going to be hard to stay competitive in almost any market. The irony is technology expedited this. As everyone knows, the most common reason for startup failure is "lack of capital." Many seem to assume this is related to venture funding or misallocation of funds. That could be part of it - But those are normally a symptom of the illness. The core problem is lack of cash flow. Or rather, free cash flow. In other words, having a bad business model. It's having to work too hard or spend too much money to generate cash (Recurring or not). This is true for a product or service business in any industry. Generally speaking businesses that succeed have done a good job of these 4 things: 1. Getting people in the door 2. Getting them to spend money 3. Getting them to spend more money 4. Getting them to do it over and over again Everything else is just nonsense or vanity. You can have an amazing idea, an amazing product, target a growing market and still fail without the above. In fact, it's pretty easy nowadays considering how easy it is to build products and identify growing markets. Many overlook this. Many overlook the fact that the "health bar" in business is only one thing - Your bank balance. You can have a terrible idea in a regressing market but if you have money in the bank - You still have options - The game isn't over. People love to talk about pivots. Well you can't pivot if the health bar is at 0. Similar to life itself, everybody has a million problems until they have a health problem - Then that becomes the only problem. The goal of business at its root is to keep the game going. To survive. "Thriving" is somewhat of a luxurious construct that is a product of media and content. The best way to "be competitive" is to survive because the greatest killer of competition is time. And this cannot be done without free cash flow. Media has made it difficult for people to think over a long time horizon due to how business content is framed - "It only took me 2 months to make 17 trillion dollars. Here's my secret." Once again - Time is the greatest killer of companies. But it is also the greatest friend to companies that succeed. It's a paradox. Without placing great importance on the core principles of what makes businesses succeed - Over a long enough time horizon - The market will just run you over.
43
12 commentaren -
Jeff McDermott
Champion Capital • 22K volgers
A lot of office hours sessions are a good back n forth going over the options that people have for their businesses, but a big chunk is putting Founders and fund managers in touch with people and vendors who can help them execute on those options that we've laid out for them. Advice is the name of the game, but the resources, connections and referrals that we make are a lot of the value that they get. Actionable steps and referrals/intros to the right people to help get those things done is where they get their money's worth!
4
-
Aramazd Demirkhanyan
esscale • 3K volgers
Fundraising isn't dating. It's a sales funnel. And most founders don't track it, so 3 months go by while they're still "in conversations." Here's the brutal math (seed round, current selectivity): 100-200 investor outreaches → 15-20% reply rate → 15-30 first meetings → 5-10 partner meetings → 1-3 term sheets → 1 close If you're not tracking conversion at each stage, you're not fundraising. You're hoping. Founders who close faster don't have better luck. They have better systems: 1. They track the funnel weekly Where are leads dying? Outreach, first meeting, partner meeting? Each bottleneck has a different fix. 2. They iterate the narrative Every week: one sharper answer to the question that killed the last meeting. 3. They batch meetings 10 meetings in 2 weeks beats 10 meetings over 2 months. Compression creates urgency. Urgency creates leverage. 4. They treat "no" as data A fast no is worth more than a slow maybe. It frees you to find the real yes. If your fundraise feels stuck, stop asking "Who else can I talk to?" Start asking "Where is my funnel breaking?" I stress-test fundraising packages for founders. Deck, model, cap table, assumptions. You get a written findings memo and a 90-minute call showing you what breaks before investors do. Link in comments. #fundraising #seedstage #venturecapital #startups
2
1 commentaar -
Alexis Grant
They Got Acquired • 14K volgers
PSA: Valuation when you raise ≠ Valuation for M&A 📣 Tough love ahead for founders who raise $... 🚫 Just because you raised money at a certain valuation... Does NOT mean you'll automatically sell for that number or more. 🚫 *** Sometimes when I take calls with founders who'd like to sell, they'll say, well, we raised at a certain valuation, so we're looking to sell for more than that. But then we'll dig into their numbers, and their EBITDA does not support a sale price anywhere near what they're hoping for. You see, most buyers want to pay some version of an EBITDA multiple. In other words, your valuation when you sell is based largely on EBITDA, plus other value-adds. But your valuation when you raise money is calculated differently. And honestly, I have no idea how it's calculated! Because I don't live in the world of venture capital. But it's clearly not calculated based on what a buyer would pay for the business. 🔹 Remember this when you go to raise funds. VC-backed companies get a lot of kudos when they raise money, and those that sell get a lot of kudos for that milestone as well. But you have to create tremendous value in between — and by value, I mean EBITDA — if you're going to sell the business for the number you raised at. Because when you go to sell, the buyers don't give a damn what you raised at. They are one massive step removed from your raise. In fact, to most buyers, your raise is irrelevant, other than knowing that founders who raise often want to pay back investors, so they'll be looking for a certain price tag no matter how well the business has performed... And that means the deal is less likely to get done. 🔹 Buyers only care about the value they're getting from you. *** "But we're not looking to sell on an EBITDA multiple." This is often what I hear after gently explaining this mismatch in expectations. Of course you don't! Nobody does 😅 But outside of a tiny fraction of strategic deals — and remember, most strategic deals happen when the buyer approaches the seller — most of your value is in your EBITDA. Yes, it's also in the brand you've built and the community you've grown and the IP you've cultivated. But those are best as value-adds, layered on *top* of EBITDA. Because most buyers want EBITDA first and foremost. To give yourself options when you sell, find ways to do all of the above. Generate EBITDA *and* win at all the intangibles that lead to revenue. That's how to get buyers to pay top dollar. But don't go into conversations about a potential exit expecting to sell for more than you raised, simply because you raised. M&A just doesn't work that way. *** I'm Alexis Grant, founder of They Got Acquired. For stories of founders who sold and how they did it, sign up for our newsletter. The link's in my bio.
54
23 commentaren -
Walker Deibel
BuildWealth • 29K volgers
You can turn $100,000 into a $50 million business through acquisitions. This is closer to capital allocation than traditional entrepreneurship. Here's the deal structure. First, the capital stack. You buy a business the same way you buy a house. Equity in, bank covers the rest. With SBA loans: 90% loan, 10% equity. A million dollar business might require $100K to $200K down. Target companies with $1 to $3 million in earnings. Go to sellers that are NOT at market. Brokered deals are competitive and sellers want cash at close. This only works off-market. Here's what you propose: Seller keeps 20% equity in a new entity. Asset sale, their company moves into newco, they keep running it at fair market salary. You write them a check for 60% via bank loan. Remaining 20% is a seller's note: 10% straight note, 10% performance earnout. From the bank's perspective, you created 40% equity. The truth? It's really only 20%, and it's the seller's. Your money in? Approaching zero. But you own 80% of Enterprise Value. Why would a seller agree? Tell them: my goal is to make your 20% as valuable as the 80% we're giving you today. What are the odds you double the value on your own in 3 to 5 years? Now stack earnings. $2 million average per company. Buy 10 just like this. $20 million combined earnings under one entity. Centralize marketing, accounting, HR, governance at HQ. You bought each at 4 to 4.5x. A $20 million earnings business sells for 7 to 7.5x or more. That's multiple expansion, just by combining them. Close the first one. Negotiate the next $100K for the next business. Then newco sells to PE for 7, 8, 9x your $20 million in earnings. That's the path from $100K to $50 million. If you're considering buying a business in the next 12 to 24 months, we built Acquisition Lab for exactly this. walkerdeibel.com
163
26 commentaren -
Weston Ginn
Bridge Angel Investors • 3K volgers
Great overview of the Florida VC ecosystem 👇 What stands out is not just the ~$2.85B raised, but how distributed and specialized each region is becoming. • South Florida → crypto, fintech, LatAm access • Tampa Bay → strong early-stage pipeline • Orlando/Space Coast → deep tech, defense, space • North Florida → emerging operator-led funds Tax advantages help, but the real story is growing density of founders, angels, and operators building locally. Still early compared to SF and NY, which is the opportunity. Who are the next Florida-based funds or angels getting active?
4
3 commentaren -
Nick King
QSBSrollover.com • 8K volgers
Secondary sales at Series A & B are booming. But did you know 90%+ of founders don't maximize QSBS during secondaries? Most founders leave $3M+ on the table for every $10M of sales. Here's why - First, these rounds are happening earlier & earlier in companies lives. Big rounds, $20M+, are now very common at the Year 2 - Year 4 mark. This is much faster than in the past. Because of the high demand to invest in these businesses, I am seeing a lot of secondary sales. Anywhere from 5% to 20% of the funding amount is being paid back to founders. The unfortunate thing here is that founders think they are missing out on QSBS with the secondary sales due to early sales. A quick reminder - when you sell before Year 5 you do not get QSBS. Unless you do a QSBS Rollover. So, for founders who are taking secondary & feel like hope is lost on getting QSBS, that may not actually be the case. A QSBS Rollover can bridge the gap to hit the 5 year mark to get QSBS.
26
-
Daureen Papinchak
Nutrition & Beauty Global LLC • 3K volgers
Olaplex went from $0 to a $13.1 billion valuation in 7 years with only twelve SKUs at their peak. How’d they do it? 𝘚𝘶𝘱𝘦𝘳𝘪𝘰𝘳 𝘏𝘦𝘳𝘰 𝘱𝘳𝘰𝘥𝘶𝘤𝘵𝘴. 𝗛𝗼𝘄 𝗢𝗹𝗮𝗽𝗹𝗲𝘅 𝗯𝘂𝗶𝗹𝘁 𝗮 𝗰𝘂𝗹𝘁 𝗳𝗼𝗹𝗹𝗼𝘄𝗶𝗻𝗴 𝘄𝗶𝘁𝗵 ‘𝗯𝗼𝗻𝗱 𝗿𝗲𝗽𝗮𝗶𝗿𝗶𝗻𝗴’ 𝘁𝗲𝗰𝗵𝗻𝗼𝗹𝗼𝗴𝘆 When Olaplex launched in 2014, they didn't just create a product—they created an entirely new category: "bond-building" haircare. Their patented technology centered on a single molecule called Bis-Aminopropyl Diglycol Dimaleate—a breakthrough designed to repair broken disulfide bonds in hair damaged by chemical, thermal, and mechanical processes. 𝗔𝘁 𝘁𝗵𝗲 𝘁𝗶𝗺𝗲, 𝘁𝗵𝗶𝘀 𝘄𝗮𝘀 𝗮 𝗿𝗲𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻𝗮𝗿𝘆 𝗮𝗽𝗽𝗿𝗼𝗮𝗰𝗵 𝘁𝗼 𝗵𝗮𝗶𝗿 𝗿𝗲𝗽𝗮𝗶𝗿. No one was talking about "repairing bonds" before Olaplex. Since then “Olaplex products review” has been viewed 1.3 billion times on TikTok. Olaplex followed three key pathways to remarkability: ✅New enemy: Hair damage from chemical processing, heat, and mechanical stress ✅R&D-led innovation: Patented bond-repair molecule that actually worked ✅ New category: Created "bond-building" as a distinct haircare segment This breakthrough triggered an arms race. Suddenly, everyone wanted products that could protect and restore damaged hair bonds. While competitors like K18 have since entered their territory, Olaplex proved the power of owning a new category first. 𝗧𝗵𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗼𝗳 𝗥𝗲𝗺𝗮𝗿𝗸𝗮𝗯𝗹𝗲 𝗣𝗿𝗼𝗱𝘂𝗰𝘁𝘀 The beauty (and nutra) space is fundamentally a storytelling competition anchored in science. Customers want remarkable products explained through compelling narratives. But how do you create something truly remarkable? Remarkability can follow one or multiple pathways (as Olaplex demonstrated): • a disruptive hypothesis (new cause) • an innovative positioning • a new enemy • an R&D-led innovation • new value propositions • a new category • a provocative design The more novel and differentiated it is, the greater its power to capture the attention and curiosity of an indifferent audience. (The brain is wired to ignore the old and pay attention to the new.) 𝗕𝗲𝘆𝗼𝗻𝗱 𝗥𝗲𝗺𝗮𝗿𝗸𝗮𝗯𝗶𝗹𝗶𝘁𝘆: 𝗧𝗵𝗲 𝗖𝗼𝗺𝗽𝗹𝗲𝘁𝗲 𝗙𝗼𝗿𝗺𝘂𝗹𝗮 When developing Hero Products, remarkability isn't enough—it must also succeed scientifically, economically, and logically. We've developed a proprietary 'Brand Magic' methodology for evaluating Hero Product potential. (More on that in future posts.) The bottom line: The best path to massive growth isn't about having 82 me-too products. It's about having one or two breakthrough acquisition products in your ecosystem that people can't live without. Olaplex proved this formula works: Start with a real problem. Create a remarkable solution. Own the category. If we want our businesses to be successful, we need to the hard work. I realize you may not want to hear that ... you're already stretched for resources. You'll need to find resources.
10
1 commentaar